Literature DB >> 16556014

Chemopreventive properties of curcumin.

Frederick C Campbell1, Gavin P Collett.   

Abstract

Inhibition of defined molecular steps of tumorigenesis by natural nontoxic compounds may be an efficient means to tackle the population cancer burden. Extensive research has addressed the chemotherapeutic potential of curcumin (diferuloylmethane), a relatively nontoxic plant-derived polyphenol. This review considers the following properties of curcumin: anticancer effects in animal model systems; metabolism; biological structure and pharmacokinetics; biological properties implicated in chemoprevention; antioxidant properties; influences upon Phase I and II carcinogen-metabolizing enzymes; signal transduction properties and the neoplastic phenotype; apoptosis evasion, cell proliferation, de-differentiation, migration and invasion and clinical studies. This review will summarize the unique properties of curcumin that may be exploited for successful clinical cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16556014     DOI: 10.1517/14796694.1.3.405

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  20 in total

1.  Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo.

Authors:  Qian-mei Zhou; Xiu-feng Wang; Xin-jun Liu; Hui Zhang; Yi-yu Lu; Shi-bing Su
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

2.  Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression.

Authors:  Jin Chen; Feng-Ling Wang; Wei-Dong Chen
Journal:  Mol Biol Rep       Date:  2014-03-07       Impact factor: 2.316

3.  Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain.

Authors:  Xiaoying Zhuang; Xiaoyu Xiang; William Grizzle; Dongmei Sun; Shuangqin Zhang; Robert C Axtell; Songwen Ju; Jiangyao Mu; Lifeng Zhang; Lawrence Steinman; Donald Miller; Huang-Ge Zhang
Journal:  Mol Ther       Date:  2011-09-13       Impact factor: 11.454

Review 4.  Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents.

Authors:  X Zhang; L-X Chen; L Ouyang; Y Cheng; B Liu
Journal:  Cell Prolif       Date:  2012-07-06       Impact factor: 6.831

5.  Analysis of the in vitro metabolites of diferuloylmethane (curcumin) by liquid chromatography--tandem mass spectrometry on a hybrid quadrupole linear ion trap system: newly identified metabolites.

Authors:  Constantin Tamvakopoulos; Zacharias D Sofianos; Spiros D Garbis; Panayotis Pantazis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jan-Mar       Impact factor: 2.441

Review 6.  Dimeric approaches to anti-cancer chemotherapeutics.

Authors:  M K Hadden; B S J Blagg
Journal:  Anticancer Agents Med Chem       Date:  2008-10       Impact factor: 2.505

Review 7.  Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy.

Authors:  Tianshu Yang; Yunkai Yang; Yan Wang
Journal:  Clin Epigenetics       Date:  2021-05-17       Impact factor: 6.551

8.  Anti cancer effects of curcumin: cycle of life and death.

Authors:  Gaurisankar Sa; Tanya Das
Journal:  Cell Div       Date:  2008-10-03       Impact factor: 5.130

9.  Comparative evaluation of the efficacy of two controlled release devices: Chlorhexidine chips and indigenous curcumin based collagen as local drug delivery systems.

Authors:  Sruthima N V S Gottumukkala; Sabitha Sudarshan; Satyanarayana Raju Mantena
Journal:  Contemp Clin Dent       Date:  2014-04

10.  Synergistic effect of combinatorial treatment with curcumin and mitomycin C on the induction of apoptosis of breast cancer cells: a cDNA microarray analysis.

Authors:  Qian-Mei Zhou; Qi-Long Chen; Jia Du; Xiu-Feng Wang; Yi-Yu Lu; Hui Zhang; Shi-Bing Su
Journal:  Int J Mol Sci       Date:  2014-09-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.